4212.0: Tuesday, October 23, 2001 - 2:42 PM

Abstract #28028

Immunization Financing in the Context of the Sector-Wide Approach: The Case of Ghana

Ann Levin, PHD, MPH, Partnerships for Health Reform, URC, 4800 Montgomery Lane, Suite 600, Bethesda, MD 20814, 301-215-5907, Ann_Levin@abtassoc.com and Joanne Jorissen, Abt Associates, 4800 Montgomery Lane, Suite 600, Bethesda, MD 20814.

Countries throughout the developing world are faced with the complexities of financing their immunization program as new vaccines are becoming available in the world vaccine market. A financial assessment of the immunization program in Ghana was conducted. The objectives of the study were the following: 1) to assess the costs and financing sources of the immunization program; 2) to evaluate the financing strategy that is being used for the immunization program; assess how successful the strategy has been in securing sufficient funding for the program as a whole, and for key components, such as vaccines, cold chain, outreach, in-service training, and personnel; and 3) to assess the costs and financial options of introducing improvements to the program.

Ghana presents a particularly interesting case to examine since it has undergone several health reforms. It decentralized its health system during the 1990’s and also began using a sector-wide approach to its health program. It has also been approved for a GFCV grant and will need to develop a financial sustainability plan in the next two years.

The assessment in Ghana examined the program within the context of its health reforms. It examined flows of funding using the sector-wide approach (SWAP) and how decentralization has affected the financing of the immunization program at the district level.

Learning Objectives: To be knowledgeable about the main issues affecting the financing of the immunization program in Ghana.

Keywords: Immunizations, Financing

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 129th Annual Meeting of APHA